Lethargic Depression Study

NCT00064467 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

268

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Major Depressive Disorder (MDD)

Interventions

DRUG: Extended-release bupropion (HCl)

Sponsor

GlaxoSmithKline